Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
<p><strong>Objectives</strong></p><p>Treat to target recommendations for PsA state that the target of treatment should be remission or, at the very least, low disease activity. Different clinical indexes have been proposed to define these disease states including the mi...
Những tác giả chính: | Coates, L, Rahman, P, Psaradellis, E, Rampakakis, E, Osborne, B, Lehman, A, Nantel, F |
---|---|
Định dạng: | Journal article |
Được phát hành: |
Oxford University Press
2018
|
Những quyển sách tương tự
-
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
Bằng: Emmanouil Rampakakis, et al.
Được phát hành: (2020-08-01) -
Golimumab for the treatment of psoriatic arthritis
Bằng: H Yang, et al.
Được phát hành: (2011-05-01) -
Golimumab in the treatment of psoriatic arthritis: efficacy and safety
Bằng: Tatiana Viktorovna Korotaeva, et al.
Được phát hành: (2015-09-01) -
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
Bằng: Proton Rahman, et al.
Được phát hành: (2020-09-01) -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Bằng: M. Rossini, et al.
Được phát hành: (2015-03-01)